Literature DB >> 17462509

The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.

Antje Kroner1, Alexander Grimm, Kirsten Johannssen, Mathias Mäurer, Heinz Wiendl.   

Abstract

Human leukocyte antigen (HLA)-G is a nonclassical major histocompatibility complex (MHC) molecule located at MHC complex at chromosome 6 and chiefly attributed immunoregulatory and tolerogenic functions. HLA-G is upregulated at sites of inflammation in multiple sclerosis (MS) and assumed to counterbalance immune responses. Different functionally relevant genetic variants of HLA-G have been described and shown to be statistically associated with human diseases such as fetal loss or sarcoidosis. We investigated the influence of three different variations in the HLA-G gene for disease susceptibility and course of MS (n = 698): (1) The -725 C/G exchange in the HLA-G promoter region, (2) HLA-G*0105N, a deletion that results in an irregular stopcodon in exon 3, and (3) a 14 bp insertion / deletion in the untranslated exon 8. None of these variations significantly influenced the susceptibility to multiple sclerosis. No association was seen with the age of onset of disease, disease severity or disease course. Although HLA-G is assumed to play an important role in the immunoregulatory processes of MS, our results do not support a role of genetic factors influencing disease susceptibility of the disease course.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17462509     DOI: 10.1016/j.humimm.2007.01.012

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  7 in total

1.  Balancing immunity and tolerance: genetic footprint of natural selection in the transcriptional regulatory region of HLA-G.

Authors:  L Gineau; P Luisi; E C Castelli; J Milet; D Courtin; N Cagnin; B Patillon; H Laayouni; P Moreau; E A Donadi; A Garcia; A Sabbagh
Journal:  Genes Immun       Date:  2014-11-13       Impact factor: 2.676

Review 2.  Genetic and Molecular Biology of Multiple Sclerosis Among Iranian Patients: An Overview.

Authors:  Meysam Moghbeli
Journal:  Cell Mol Neurobiol       Date:  2019-09-03       Impact factor: 5.046

3.  Copy number variation in pediatric multiple sclerosis.

Authors:  J P McElroy; L B Krupp; B A Johnson; J L McCauley; Z Qi; S J Caillier; P A Gourraud; J Yu; L Nathanson; A L Belman; S L Hauser; E Waubant; D J Hedges; J R Oksenberg
Journal:  Mult Scler       Date:  2012-12-13       Impact factor: 6.312

4.  A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.

Authors:  Bruce A C Cree; John D Rioux; Jacob L McCauley; Pierre-Antoine F D Gourraud; Philippe Goyette; Joseph McElroy; Philip De Jager; Adam Santaniello; Timothy J Vyse; Peter K Gregersen; Daniel Mirel; David A Hafler; Jonathan L Haines; Margaret A Pericak-Vance; Alastair Compston; Stephen J Sawcer; Jorge R Oksenberg; Stephen L Hauser
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

Review 5.  Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association.

Authors:  Eduardo A Donadi; Erick C Castelli; Antonio Arnaiz-Villena; Michel Roger; Diego Rey; Philippe Moreau
Journal:  Cell Mol Life Sci       Date:  2010-11-24       Impact factor: 9.261

Review 6.  HLA-G Molecules in Autoimmune Diseases and Infections.

Authors:  Roberta Rizzo; Daria Bortolotti; Silvia Bolzani; Enrico Fainardi
Journal:  Front Immunol       Date:  2014-11-18       Impact factor: 7.561

7.  Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis.

Authors:  Martin Feuchtenberger; Sabine Müller; Petra Roll; Anne Waschbisch; Arne Schäfer; Christian Kneitz; Heinz Wiendl; Hans-Peter Tony
Journal:  Open Rheumatol J       Date:  2008-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.